Professional Documents
Culture Documents
Off Label Use of Drugs PDF
Off Label Use of Drugs PDF
FDA approval for specific indication
1
Clomipramine
Tricyclic antidepressant
**
___________________________
*** ( for
) premature ejaculation
Anafranil
2
Phenytoin
)epilepsy)
**
)wound healing(
stimulation of fibroblast proliferation,
facilitation of collagen deposition
**
3
Sildenafil
D:
phosphodiestrase
cGMP
) (Erectile dysfunction
blood supply to penis
** pulmonary hypertension
right sided heart failure
4
Spironolactone
k-sparing diuretic
thiazide k ,
5
Methotrexate
__________________________________
** (Ectopic
) pregnancy
,
Erythromycin
Macrolides
G+v
____________________________________
**
Prokinetic
7
Domperidone
Dopamine antagonist
(
)
____________________________
**
8
Clomiphene
:D
,
** off label
( )Hyopgonadism
:D
hypothalamus
LH
)) Sperm
,
( )
LH
Ve feedback
LH
:
9
Cabergoline
Dopamine agonist
,
, ( )
**
() Anorgasmia
delayed ejaculation
orgasm
( ) SSRI
**
premature
ejaculation ( )
:
01
Bupropion
sec line of ttt after SSRI
Weak serotonin and noradrenalin reuptake
inhibitor
epilepsy
___________________________________
**
**
Wellbutrine
00
Acetylcysteine
)N-acetyl l-cysteine (NAC
Disulfide linkage
Mucous
**
. liver
NAC
)(Paracetamol antidote
IV or Oral
Glutathione
toxic metabolite
NAPQI
**
*
Mucolytic
Acetyl cysteine
12
Cyproheptadine
1st generation antihistamincs
___________________________________
**
13
Tamsulosin
) ) Alpha 1 blocker drug
BPH
anatomy of UT
__________________________________
**
Alpha receptor
14
Metformin
DM type 2
__________________________________
**
,
Hyperandrogenism
Hormonal imbalance induced acne
15
Lactulose
__________________________________
** .
\:
Lactic acid
Acidic media
NH3 to NH4
colon blood
**
)Neomycin (Antibiotic
Bacterial flora
16
Finasterid
Testosterone to dihydrotestosterone (active
)form
BPH
________________________________
**
Anti androgenic effect
17
Trypsin & chemotrypsin
,
Hoarseness of voice
:D
Larynx
Laryngitis
GERD
Epiglottitis
Laryngeal or thyroid cancer
**
:
Alphintern
Ambezim
18
Paroxetine
SSRI
19
Dexamethasone
:D
Arachidonic acid
___________________________________
3 4
Surfactant
.
Synergism Ondansetron
22
Gabapentin
**
Bipolar disorder
()
:D
21
Nitroglycerin
Ca channel blocker
2 Off label use
,
Anti angina
ca channel blocker
Verapamil
After and preload
_________________________________
**
Anal fissure
blood supply
.
:
Nitromak
Dinitra
Effox
Ca channel blocker
22
Acetyl salicylic acid
)(aspirin
Potent anti inflammatory , analgesic , anti pyretic
NSAIDS
COX 1 , 2 enzymes
______________________________
**
,
))Anti platelet
23
Phenobarbitone
)(long acting barbiturate
** Drug interaction
Liver enzymes inducer
2 3
)Sominaletta syr (phenobarbitone
Bilirubin
24
Adrenaline
Anaphylactic shock
asthma cardiac arrest
______________________________
**
Potent vasoconstrictor effect
25
NSAIDS
:D
__________________________________
**
ACEI induced cough
.
)Angiotensin converting (AC
Bradykinin
vagal effect
Arachidonic acid
NSAIDS
**
Shift from ACEI to ARB (angiotensin receptor
) blocker
NSAIDS
..
Sulindac
Meloxicam
26
Topiramate
Approval 1996
_________________________________
** FDA approval
2212 weight loss
Side effect not effect
Not clear
Topamax
27
Propranolol
Non selective beta blocker
__________________________________
**
Hyperthyrodism
(L) and (D) isomer
L-propranolol
Beta blocking activity
D-propranolol
22
Acetazolamide
Mild diuretic lowering Nacl and bicarbonate level
Carbonic anhydrase
( 3 )
edema
_______________________________
**
Glaucoma
Aqueous humor
**
Sulphonamide derivative
29
Latanoprost
Travoprost
Bimatoprost
:D
32
Insulin
Treatment of DM type 1
________________________________
**
...
substrate
31
Misopristol
Mucous Hcl
________________________________
**
32
SSRI
Selective serotonin
reuptake inhibitors
TCA
...................
________________________________
**
Dapoxetine
ssri
SSRI **
Escitalopram
Dapoxetine